Pareto Biotechnologies
Biotechnology, Chemical, Renewable Energy
Founded in 2013-01-01
San Francisco, California, United States
For Profit
About Pareto Biotechnologies
Pareto Biotechnologies has pioneered development of a revolutionary synthetic biology platform that produces naturally derived, high value “designer molecules.” Pareto’s technology is the result of over a decade of academic and private sector research and intellectual property focused on one particular polyketide pathway. Building on Dr. Joe Noel’s groundbreaking research at the Salk Institute, this pathway – previously dismissed as the “poor man’s pathway” – is the foundation of Pareto’s platform, capable of generating known products and novel molecules.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: None USD
- Last Funding: None (Venture - Series Unknown)
- Funding Status:
Technology Stack
Pareto Biotechnologies actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Chemical, Renewable Energy
Headquarters: San Francisco, California, United States